YOLFTbeta
17

Nang Kuang Pharmaceutical Co Ltd

1752 · TW · Healthcare / Medical Instruments & Supplies

30.10TWD+0.10 (+0.33%)

Price History

Full chart

Market Stats

Previous Close30.00
Open30.00
Day Range30.00 – 30.20
52-Week Range30.65 – 37.64
Volume26.42K
Market Cap3.17B
P/E (TTM)15.52
Forward P/E0.00
EPS2.02
Dividend Yield5.08%
Beta0.14
50-Day Avg31.64
200-Day Avg34.18

About

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in alimentary and metabolism, blood, antineoplastic and immunomodulatory, dermatological, genito-urinary and sex hormone, systemic hormone and antibacterial, cosmetics, and hospital solutions. In addition, the company is involved in trading of pharmaceuticals. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMs. Yu-Bei Wang
  • Employees0
  • HeadquartersNo. 1001, Zhongshan Road, Tainan City, Taiwan, 71243, Taiwan
  • Websitehttps://www.nangkuang.com.tw

Leadership

  • Ms. Yu-Bei WangGeneral Manager
  • Ling-Jun TuChief Financial Officer
  • Lizhen LaiAccounting Supervisor
  • Hsiu-Mei ChaoAccounting Officer & Chief Internal Auditor

Financials

Income Statement

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue670.03M652.83M813.12M952.14M1.01B1.28B1.52B1.55B1.50B1.54B1.76B1.75B1.78B1.94B2.15B2.20B2.16B
Growth (%)--2.57%+24.55%+17.10%+6.38%+26.05%+19.07%+1.93%-2.97%+2.31%+14.54%-0.42%+1.44%+9.01%+10.81%+2.31%-1.71%
Cost of Revenue432.71M449.26M561.83M624.12M716.40M867.27M971.00M974.00M987.38M1.04B1.14B1.16B1.19B1.25B1.39B1.45B1.39B
Gross Profit237.32M203.56M251.30M328.02M296.52M409.51M549.33M575.71M516.35M499.51M622.30M596.76M594.47M694.90M755.56M747.79M768.86M
Gross Margin35.42%31.18%30.91%34.45%29.27%32.07%36.13%37.15%34.34%32.47%35.31%34.01%33.40%35.81%35.14%33.99%35.56%
Operating Expense218.00M211.68M219.00M225.00M280.74M318.48M313.18M299.56M294.55M376.45M366.20M366.29M360.71M277.23M495.65M440.25M473.19M
Operating Income19.32M-8.12M32.30M103.01M15.78M91.03M236.15M276.15M221.80M123.07M256.11M230.47M233.76M417.67M259.91M307.55M295.67M
Operating Margin2.88%-1.24%3.97%10.82%1.56%7.13%15.53%17.82%14.75%8.00%14.53%13.13%13.13%21.52%12.09%13.98%13.67%
EBITDA92.24M76.64M123.97M219.73M136.95M244.28M378.00M447.71M339.54M318.31M447.01M412.99M417.83M591.57M402.70M491.69M478.81M
EBITDA Margin13.77%11.74%15.25%23.08%13.52%19.13%24.86%28.89%22.58%20.69%25.37%23.53%23.47%30.49%18.73%22.35%22.14%
Net Income11.94M-10.59M6.16M80.37M-7.82M67.28M198.99M225.50M185.82M101.23M217.44M183.40M196.11M352.00M198.41M243.41M243.95M
Net Income Margin1.78%-1.62%0.76%8.44%-0.77%5.27%13.09%14.55%12.36%6.58%12.34%10.45%11.02%18.14%9.23%11.06%11.28%
R&D44.99M55.74M80.28M73.31M103.95M114.44M106.28M116.40M135.84M154.68M130.77M159.80M133.97M143.81M164.11M169.36M169.69M
R&D as % of Total Revenue6.71%8.54%9.87%7.70%10.26%8.96%6.99%7.51%9.03%10.05%7.42%9.11%7.53%7.41%7.63%7.70%7.85%
Interest Expense5.39M10.93M13.92M15.46M10.08M8.43M9.52M5.94M4.13M4.49M3.47M4.31M3.53M4.84M7.18M5.53M8.59M
Interest Expense % of Total Revenue0.80%1.67%1.71%1.62%0.99%0.66%0.63%0.38%0.27%0.29%0.20%0.25%0.20%0.25%0.33%0.25%0.40%

Balance Sheet

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.71B1.85B2.09B2.42B2.61B2.76B3.05B3.17B3.33B3.03B3.29B3.26B3.43B3.58B3.86B3.81B3.82B
Total Liabilities891.18M1.05B1.29B1.49B1.18B1.31B1.05B1.05B1.19B974.64M1.10B1.06B1.19B1.17B1.48B1.39B1.33B
Total Equity816.05M803.36M802.34M928.02M1.43B1.44B1.99B2.12B2.14B2.05B2.19B2.20B2.24B2.41B2.38B2.42B2.48B
Cash39.40M54.35M107.66M93.69M147.84M226.41M287.57M346.27M351.50M176.55M391.95M266.46M417.12M401.20M378.48M301.54M345.67M
Total Debt727.15M816.09M757.59M1.10B991.17M1.06B756.23M760.31M787.91M476.19M477.84M431.50M533.54M409.50M605.96M638.45M655.95M
Net Debt687.75M761.74M649.93M1.00B843.33M834.36M468.66M414.04M436.41M299.64M85.89M165.03M116.42M8.30M227.49M336.90M310.28M

Cash Flow

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow96.60M67.80M50.67M161.92M83.18M224.83M348.23M404.99M322.71M366.12M386.19M151.01M556.63M369.19M342.61M466.43M464.08M
Investing Cash Flow-242.95M-242.09M-215.22M-365.94M-195.29M-135.40M-314.34M-252.37M-229.88M-154.42M-76.22M-112.01M-291.48M-109.85M-329.51M-372.39M-281.94M
Financing Cash Flow113.41M189.25M217.85M190.05M166.25M-10.86M27.27M-93.90M-87.61M-386.65M-94.57M-164.48M-114.48M-275.31M-35.77M-170.97M-138.02M
Capital Expenditure241.41M242.44M218.71M365.19M188.23M107.56M298.79M229.42M204.55M155.74M74.98M91.69M159.74M94.17M300.73M525.91M281.04M
Free Cash Flow-144.81M-174.64M-168.04M-203.28M-105.04M117.27M49.45M175.57M118.16M210.38M311.21M59.32M396.89M275.02M41.87M-59.49M183.03M
Dividends Paid55.50M12.60M-12.60M22.41M25.00M44.58M60.17M161.58M161.58M90.07M121.19M151.48M156.53M201.98M100.99M80.79M
FCF to OCF-149.91%-257.58%-331.62%-125.54%-126.28%52.16%14.20%43.35%36.62%57.46%80.58%39.28%71.30%74.49%12.22%-12.75%39.44%
Dividend Paid to FCF-38.33%-7.21%--6.20%-21.34%21.32%90.16%34.27%136.75%76.80%28.94%204.29%38.17%56.92%482.34%-169.76%44.14%

Earnings

Report DateOct 28, 2011Mar 19, 2012Jul 15, 2012Oct 29, 2012Mar 27, 2013Nov 11, 2014Mar 18, 2015Apr 1, 2015Aug 14, 2015Nov 10, 2015Mar 28, 2016Aug 15, 2016Nov 7, 2016Mar 24, 2017Apr 3, 2017Aug 14, 2017Nov 6, 2017Mar 13, 2018May 9, 2018Aug 6, 2018Nov 9, 2018May 9, 2019Aug 7, 2019Nov 10, 2019Mar 24, 2020May 8, 2020Aug 7, 2020Nov 8, 2020Mar 4, 2021May 5, 2021Aug 5, 2021Nov 5, 2021Mar 3, 2022May 4, 2022Aug 7, 2022Nov 4, 2022Mar 5, 2023May 4, 2023Mar 6, 2025
EPS Estimate0.170.250.350.420.500.220.310.330.440.740.540.650.570.790.400.630.700.551.050.610.410.330.540.530.570.600.720.800.480.540.65--0.490.570.490.76-0.57
EPS Actual-0.040.020.340.320.120.280.440.440.440.620.550.490.410.670.670.350.330.510.380.360.080.350.410.600.800.620.430.290.480.440.540.450.510.410.740.741.600.930.86
Surprise-123.53%-92.00%-2.86%-23.81%-76.00%27.27%41.94%33.33%0.00%-16.22%1.85%-24.62%-28.07%-15.19%67.50%-44.44%-52.86%-7.27%-63.81%-40.98%-80.49%6.06%-24.07%13.21%40.35%3.33%-40.28%-63.75%0.00%-18.52%-16.92%---16.33%29.82%51.02%110.53%-50.88%
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap3.17B
Enterprise Value3.47B
Trailing P/E15.52
Forward P/E0.00
Price / Sales1.50
Price / Book1.32
EPS2.02
Book Value23.84
Revenue (TTM)2.11B
Gross Profit (TTM)734.20M
EBITDA441.04M
Profit Margin9.74%
Operating Margin14.12%
Return on Equity8.50%
Return on Assets4.21%
Shares Outstanding100.99M
Shares Float41.64M
Beta0.14
Dividend Yield5.08%
Dividend Rate1.60
Payout Ratio79.07%

Dividends

20261×
1.60Jul 2, 2026
20251×
1.60Jul 3, 2025
20241×
2.00Jul 4, 2024
20231×
2.30Jun 20, 2023
20221×
1.80Jun 29, 2022